From: Characterization and toxicity evaluation of degradation products of febantel
Compound | GI absorption | BBB permeant | PgP substrate | CYP1A2 inhibitor | CYP2C19 inhibitor | CYP2C9 inhibitor | CYP2D6 inhibitor | CYP3A4 inhibitor |
---|---|---|---|---|---|---|---|---|
Febantel | Low | No | No | No | Yes | Yes | No | No |
DP-I | Low | No | Yes | No | Yes | Yes | No | No |
DP-II | Low | No | No | No | Yes | Yes | No | No |
DP-III | High | No | No | No | No | Yes | No | No |
DP-IV | High | No | No | Yes | Yes | Yes | Yes | Yes |
DP-V | Low | No | No | No | Yes | Yes | No | No |